Literature DB >> 13126805

Treatment of chronic discoid lupus erythematosus with quinacrine.

B L RHODES, M F ALLENDE.   

Abstract

Twenty-five patients with chronic discoid lupus erythematosus were treated with quinacrine hydrochloride for periods of two to six months. Twenty-one had satisfactory results.

Entities:  

Keywords:  LUPUS ERYTHEMATOSUS/therapy; QUINACRINE/therapeutic use

Mesh：

Substances：

Year:  1954        PMID： 13126805      PMCID： PMC1531780     

Source DB:  PubMed          Journal:  Calif Med        ISSN： 0008-1264


  6 in total

1.  Lupus erythematosus treated with mepacrine.

Authors:  J SOMMERVILLE; D C DEVINE; J C PURSE
Journal:  Br J Dermatol       Date:  1952-11       Impact factor: 9.302

2.  A study of the local tissue reactions in man to cortisone and compound F. VI. Histopathological studies of the local effect of compound F in normal and pathologic skin of man.

Authors:  L GOLDMAN; H O'HARA; J BASKETT
Journal:  J Invest Dermatol       Date:  1953-04       Impact factor: 8.551

3.  Atabrine in the treatment of discoid lupus erythematosus.

Authors:  J A CRAMER; G M LEWIS
Journal:  J Invest Dermatol       Date:  1952-12       Impact factor: 8.551

4.  Treatment of chronic discoid lupus erythematosus with atabrine.

Authors:  G C WELLS
Journal:  J Invest Dermatol       Date:  1952-12       Impact factor: 8.551

5.  Pharmacologic and pathogenetic effects of mepacrine chloride (atabrine) upon the human skin. II. Microscopic studies of vital staining effects in the skin.

Authors:  F HERRMANN; O B MILLER
Journal:  Acta Derm Venereol       Date:  1952       Impact factor: 4.437

6.  Therapeutic assays of the Skin and Cancer Unit of the New York University Hospital. Assay VII-Quinacrine hydrochloride (atabrine hydrochloride) for chronic discoid lupus erythematosus.

Authors:  H H SAWICKY; N B KANOF; M G SILVERBERG; M BRAITMAN; B KALISH
Journal:  J Invest Dermatol       Date:  1952-12       Impact factor: 8.551
  6 in total
  1 in total

1.  Systemic lupus erythematosus; a report on twelve cases treated with quinacrine (atabrine) and chloroquine (aralen).

Authors:  S K CONNER
Journal:  Ann Rheum Dis       Date:  1957-03       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.